Menu
Services
Custom Research & Development
Nucleic Acid
siRNA
In Vitro
Screening Service
One-Stop Antisense Oligonucleotide (ASO) Development
Circular RNAs (circRNAs) Services
Viral Vector
Adeno-associated Virus Vector
Adenoviral Vector Development Service
Lentiviral Vector Development Service
Herpes Simplex Virus Vector Development Service
Vaccinia Viral Vector Development Service
Baculovirus Vector
Other Viral Vectors
Custom Production
Viral Vector
Nucleic Acid
Custom Formulation & Conjugation
Lipid Nanoparticle (LNP)
Mitochondrial Targeting LNP
Antibody-siRNA Conjugates (ARCs)
Antibody-Oligo Conjugates (AOCs)
N-Acetylgalactosamine (GalNAc)
Others
Development of Polyplexes as Gene Delivery System
Development of Dendrimers as Gene Delivery System
Development of Stem Cells as Gene Delivery System
Development of Dendritic Cell as Gene Delivery System
Development of Bacteria as Gene Delivery System
Custom Aptamer Screening
Custom Nanoparticles Service
Custom Polymers Service
Custom Nucleic Acid Nanostructure Service
Custom Exosomes Service
GTOnco™ Immuno-Oncology Assay Services
GTOnco™ I-O Assays for
In Vitro
Study
GTOnco™ I-O Assays for
In Vivo
Study
Analytical Testing & Quality Control
Nucleic Acid Anaylsis
Identity of Nucleic Acid
Concentration of Nucleic Acid
Safety of Nucleic Acid
Potency of Nucleic Acid
Purity of Nucleic Acid
Viral Vector Analysis
Identity of Viral Vector
Titer of Viral Vector
Safety of Viral Vector
Potency of Viral Vector
Purity of Viral Vector
Other Service
Mitochondrial Toxicity Assay
RNA Profiling Service
CRISPR assisted Gene Editing Solutions
CRISPR assisted Cell Line Development
Gene Knockout
Gene Knock-in
Point Mutation
Cas9 Overexpressing Cell Line Development
dCas9-VPH Overexpressing Cell Line Development
dCas9-VPR Overexpressing Cell Line Development
dCas9-KRAB Overexpressing Cell Line Development
CRISPR based Screening Solutions
Genome-Wide CRISPR Screening
CRISPRa Screening
CRISPRi Screening
Single-Cell CRISPR Screening
Custom CRISPR Screening
CRISPR related Delivery Agent Construction
Lipid Nanoparticle (LNP) Formulation through CRISPR
Viral Vector Construction through CRISPR
gRNA Cloning through CRISPR
Gene Editing Donor Vector Construction through CRISPR
Disease Modeling related Gene Editing
Library Design through CRISPR
Nuclease Activity Measurement
Products
Antisense Oligonucleotides (ASOs)
Cancer
Cytomegalovirus Retinitis
Familial Hypercholesterolemia
Viral Hemorrhagic Fever
HIV/AIDS
Spinal Muscular Atrophy
Duchenne Muscular Dystrophy
Hypertriglyceridemia
ASO Others
Recombinant Virus
Recombinant Adeno-Associated Virus
Recombinant Adenovirus
Recombinant Lentivirus
Recombinant Retrovirus
SARS-CoV-2 Research
Pseudovirus
Overexpressing Virus
Small Interfering RNA (siRNA)
Circular RNAs (circRNAs) Products
Reporter Circular RNA Products
Platforms
GTOnco™ Platform for Gene Therapy-based I-O Drug Development
Therapeutic Areas
Gene Therapy Development for Diseases
Gene Therapy Development for Genetic Disorders
Gene Therapy Development for Acquired Diseases
Resources
Support Knowledge
In Vivo
Cell Therapy: Advancing Precision Medicine Through Direct Cellular Interventions
Application of gene therapy in cancer treatment- From theory to preclinical research
Application of Adeno-associated Viral Vectors in the Central Nervous System
Therapeutic Nucleic Acids
Approaches to Genome Editing
Strategies for Gene Delivery
Gene Therapy in Clinical Trials
Genes and Associated Diseases
Gene Therapy for Human Genetic Disorders
Strategies for Circular RNA Synthesis
Podcasts
Webinars
Programmable Molecular Tools for Biology and Genome Editing
Development of Gene Therapy for Genetic Hearing Loss
Optimal Therapeutic Intervention Timepoints for siRNA-Based Huntington's Disease Therapies
About Us
Careers
Contact Us
Inquiry
Company
About Us
Careers
Contact Us
Inquiry
Service Search
Product Search
Keyword Search
Home
Search for "Cntnap1"
Search for "Cntnap1"
siRNA, Anti-Human CNTNAP1
(CAT#: SIRGT25357WQ)
Species
: Human
Target
: CNTNAP1
Datasheet
INQUIRY
siRNA, Anti-Human CNTNAP1, 2'-OMe
(CAT#: SIRGT26357WQ-2OMe)
Species
: Human
Target
: CNTNAP1
Datasheet
INQUIRY
siRNA, Anti-Human CNTNAP1, 2'-F
(CAT#: SIRGT27357WQ-2F)
Species
: Human
Target
: CNTNAP1
Datasheet
INQUIRY
siRNA, Anti-Human CNTNAP1, 2'-MOE
(CAT#: SIRGT28357WQ-2MOE)
Species
: Human
Target
: CNTNAP1
Datasheet
INQUIRY
siRNA, Anti-Human CNTNAP1, LNA
(CAT#: SIRGT29357WQ-LNA)
Species
: Human
Target
: CNTNAP1
Datasheet
INQUIRY
siRNA, Anti-Human CNTNAP1, Ribo-modified
(CAT#: SIRGT26357WQ-RB)
Species
: Human
Target
: CNTNAP1
Datasheet
INQUIRY
siRNA, Anti-Human CNTNAP1, Backbone-modified
(CAT#: SIRGT27357WQ-BB)
Species
: Human
Target
: CNTNAP1
Datasheet
INQUIRY
